Roche gets EU nod for Avastin

08/24/2007 | Forbes · Wall Street Journal (free content), The

The European Union will allow Avastin to be sold in the region for the treatment of advanced non-small cell lung cancer, Roche Holding AG announced. The drug, which was developed by Roche with Genentech, will be used in combination with platinum-based chemotherapy. Genentech has also reapplied with the FDA seeking approval for the drug's use in treating breast cancer.

View Full Article in:

Forbes · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC